Crucible · Firm report card
Xeris Pharmaceuticals, Inc.
TX · SBIR awardee across 1 federal program (HHS/NIH), first award 2009.
12SBIR awards
$9MSBIR $
6 → 6Phase I → II
$0Follow-on federal $
0Follow-on contracts
SBIR awards by program
| Program | Awards | SBIR $ | Phase I | Phase II |
|---|---|---|---|---|
| HHS/NIH | 12 | $9M | 6 | 6 |
Mission areas
Open the interactive profile of Xeris Pharmaceuticals, Inc. →Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.
Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology